On Thursday, Sage Therapeutics, Inc. (NASDAQ:SAGE) announced a strategic reorganization of its business operations to support ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Sage Therapeutics' dalzanemdor failed to show significant results in Phase 2 Alzheimer's study. The company discontinues ...

The company faced disappointment with the Phase 2 KINETIC study of SAGE-324 (BIIB124) in essential tremor, which failed to meet its primary endpoint. This setback, along with other recent pipeline ...

Sage Therapeutics, Inc. SAGE announced that partner Biogen BIIB has terminated its rights related to the investigational ...

The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...

The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...

The companies recently announced negative results from the Phase 2 KINETIC 2 Study of investigational SAGE-324 for the chronic treatment of essential tremor (ET) and discontinued further clinical ...

In a post on X, previously known as Twitter, Joburg Emergency Medical Services (EMS) spokesperson, Robert Mulaudzi, said the earth tremor experienced in most parts in Joburg south, affecting ...

The Council of Geoscience (CGS) has confirmed an earth tremor hit parts of Johannesburg and the West Rand on Tuesday evening. A slight tremor hit parts of Gauteng late on Tuesday evening at around ...